San Diego-based Biotech Expands for Future Growth and Top Talent
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-biolegend.jpg" NAME"San Diego-based Biotech Expands for Future Growth and Top Talent" ALT"San Diego-based Biotech Expands for Future Growth and Top Talent"August 7, 2017By Alex Keown, BioSpace.com Breaking News Staff<BR...…
Acorda Investor Urges for Company to Explore Sale
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks5.jpg" NAME"Acorda Therapeutics Investor Urges for Company to Explore Sale" ALT"Acorda Therapeutics Investor Urges for Company to Explore Sale"August 7, 2017By Mark Terry, BioSpace.com Breaking News Staff<BR... Source: BioSpace
Gemphire Shares Drop on Disappointing Phase II Results for LDL Drug
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks-down2.jpg" NAME"Gemphire Shares Drop on Disappointing Phase II Results for LDL Drug" ALT"Gemphire Shares Drop on Disappointing Phase II Results for LDL Drug"August 7, 2017By Alex Keown, BioSpace.com Breaking…
Vernalis Hit by U.S. Setback for Cough and Cold Drug CCP-08
Life Sciences Jobs ... Source: BioSpace
FDA Hits Fusion IV for Incomplete Labeling, Environmental Monitoring
The FDA cited Fusion IV Pharmaceuticals for incomplete labels and failing to properly monitor environmental conditions. Source: Drug Industry Daily
EMA Seeks Comments on Planned Nonclinical Guidance for Radiopharmaceuticals
The European Medicines Agency invited stakeholders to comment on a planned guidance on nonclinical development of radiopharmaceutical products. Source: Drug Industry Daily
- Go to the previous page
- 1
- …
- 360
- 361
- 362
- 363
- 364
- 365
- 366
- …
- 610
- Go to the next page